FDA Investigator Richard A Abate
Richard A Abate has inspections in 1 countries as of 04 Nov 2022. Richard A Abate has collaborated with a combined 1078 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
04 Nov 2022
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amalia C Himaya,
Angela Shepas,
Binh T Nguyen,
Bo Chi, PhD,
Bryan A Galvez,
Byungja E Marciante,
Carr Sharpe,
Carrie A Hughes,
Caryn M Mcnab,
Cassandra L Abellard,
Charlotte Hinkle,
Chiang Syin, PhD,
Christopher D Washington,
Christopher M Jenner,
Cynthia Jim, CSO,
Cynthia Whitmarsh,
Darin S Wiegers,
David H Smith,
Dr. Robert C Horan, MD,
Erik W Koester,
Gary J Hagan,
Hinh T Nguyen,
Joey V Quitania,
John P Mistler,
Jonathan G Matrisciano,
Jonee J Mearns,
Judy C Nepsa,
Justin A Boyd,
Justine M Corson,
Kari M Johansen,
Kham Phommachanh,
LCDR Debra Emerson,
Li Yun Huang,
Liming Zhang,
Linda Thai,
Mariza M Jafary,
Matthew C Watson,
Megan A Haggerty,
Michael D Garcia,
Michael Serrano,
Mihaly S Ligmond,
Namita Kothary,
Natalie J Ayoub,
Paul L Bellamy,
Prabhu P Raju,
Rabin N Ghoshal,
Richmond K Yip,
Robert Mo Brien,
Rory K Geyer,
Sean P Desbrow,
Shirley S Wen,
Simone E Pitts,
Stacey S Degarmo,
Stephen J Mottola,
Sumit Sen,
Tara L Stockton,
Thomas J Arista,
Truong Xuan Nguyen (Andy),
Vashti E Bocker,
Vioela J Caze,
Virgilio F Pacio, CSO,
Yi Lin,
Yvonne T Lacour,
Ze Peng
Richard A Abate's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2016 | FDA 483 | Bausch Health Companies, Inc. - Form 483, 2016-05-17 |
May, 2016 | EIR | Bausch Health Companies, Inc. - EIR, 2016-05-17 |
April, 2017 | FDA 483 | Biogen, Inc. - Form 483, 2017-04-06 |
August, 2018 | EIR | Nexgen Pharma, Inc. - EIR, 2018-10-04 |
August, 2018 | FDA 483 | Nexgen Pharma, Inc. - Form 483, 2018-08-17 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more